Complaint in Erwin Hurlbut v. GW Pharmaceuticals Plc, described as a British “biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas” whose shares are listed on NASDAQ; Geoffrey Guy, Justin Gover, Cabot Brown, David Gryska, Catherine Mackey, James Noble, Alicia Secor, and William Waldegrave at the U. S. District Court for the Eastern District of Pennsylvania.
- Home
- Documents
- Type
- Court Filings
- Civil
- Erwin Hurlbut v. GW Pharmaceuticals Plc et al: Complaint
Civil Complaint Courts Documents Investment Listed Securities United Kingdom United States District Court for the Eastern District of Pennsylvania USAMarch 30, 2021
Erwin Hurlbut v. GW Pharmaceuticals Plc et al: Complaint
12
March 30, 2021
GW Pharmaceuticals Plc, Geoffrey Guy, Justin Gover, Cabot Brown, David Gryska, Catherine Mackey, James Noble, Alicia Secor, William Waldegrave
Topics
Investment Listed Securities USA United KingdomKeywords
Alicia Secor Cabot Brown Catherine Mackey David Gryska Erwin Hurlbut